Clinical Trial Update: MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating whether escitalopram treatment in patients undergoing coronary artery bypass grafting improves outcomes by addressing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Hopital Jean Minjoz | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED